We’re revolutionizing gene delivery to expand the impact of genetic medicines.
Our goal is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.
About Us
Our Team
Emily Beura
Associate Director, T Cell Biology
Steve Cassidy
Senior Manager, Facilities & Lab
Jennifer Curry
Vice President, HR
Connor Dobson
Scientist II
Shirley Dong
Associate Scientist II
Josue Figueroa
Principal Associate Scientist
Kevin Friedman
Chief Scientific Officer, President
Thomas Galbo
Chief Business Officer
Shannon Grande Contrastano
Senior Director, Preclinical Sciences
Ann Grosse
Senior Director, Program Management
Jose Hurtado
Scientist
Sanath Janaka
Senior Scientist
Ricky Lane
Associate Director, Analytical Development
Howie Latimer
Principal Associate Scientist
Maggie Lau
Associate Scientist II
Ryan Lynch
Vice President of Finance
Kaiysa Mendy
Office Manager/HR Coordinator
Jessica Murray
Associate Scientist I
Gabi Ndakwah
Associate Scientist I
Jenifer Obrigewitch
Senior Associate Scientist II
Molly Perkins
Vice President of Research
Jon Platt
Director, LVV CMC
Bharat Reddy
Vice President, Strategy and Business Development
Jose Sanabria
Principal Associate Scientist
Steve Sazinsky
Vice President, Biotherapeutics Engineering
Alyson Warr
Scientist II
Denise Wong
Senior Associate Scientist II
Our Board
Michael Birnbaum
Professor of Biological Engineering, MIT
Michael Fischbach
Professor of Bioengineering, Stanford
Kevin Friedman
Chief Scientific Officer, President
Bob More
Managing Director, Alta Partners
Bryan Roberts
Partner, Venrock
Our Investors
